# Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

> **NCT05718531** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Ectasia

## Interventions

- **DRUG:** Rivaroxaban 2.5 Mg Oral Tablet twice daily
- **DRUG:** Clopidogrel 75 Mg Oral Tablet
- **DRUG:** Aspirin tablet 75 mg

## Key facts

- **NCT ID:** NCT05718531
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2025-02
- **Final completion:** 2025-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718531, "Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05718531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*